[ad_1]
“The decision will be made at the beginning of this week,” Aistė Šuksta, a spokesman for the Health Minister, told BNS on Monday.
The European Medicines Agency last week approved the use of AstraZeneca in adult citizens of European Union countries.
The Agency stated in its report that there are currently insufficient studies on the effects of the vaccine in people over 55 years of age, but that the vaccine is expected to provide protection based on other data, including the effects of other vaccines.
The company promises to deliver 30 percent. more vaccinations than promised last week.
Lithuania is expected to receive the first shipments of the AstraZeneca vaccine on February 7.
So far, Lithuanian residents have been vaccinated with the Pfizer-BioNTech and Moderna vaccines.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
